📗 Cite This Artifact
Icahn School of Medicine at Mount Sinai
<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Icahn School of Medicine at Mount Sinai</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>New York, NY, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical School</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://icahn.mssm.edu/" target="_blank">https://icahn.mssm.edu/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](//alzheimers), Genomics, Systems Biology</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Department of Neuroscience<br>Alzheimer's Disease Research Center</td>
</tr>
</table>
Icahn School of Medicine at Mount Sinai
Overview
...<table class="infobox infobox-institution">
<tr>
<th class="infobox-header" colspan="2">Icahn School of Medicine at Mount Sinai</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Logo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Location</td>
<td>New York, NY, USA</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Medical School</td>
</tr>
<tr>
<td class="label">Website</td>
<td><a href="https://icahn.mssm.edu/" target="_blank">https://icahn.mssm.edu/</a></td>
</tr>
<tr>
<td class="label">Focus Areas</td>
<td>[Alzheimer's Disease](//alzheimers), Genomics, Systems Biology</td>
</tr>
<tr>
<td class="label">Departments</td>
<td>Department of Neuroscience<br>Alzheimer's Disease Research Center</td>
</tr>
</table>
Icahn School of Medicine at Mount Sinai
Overview
Icahn School of Medicine at Mount Sinai is a premier medical school and research institution located in New York, NY, USA["@icahn2024"]. Mount Sinai has established itself as a leader in applying genomics and systems biology approaches to understand neurodegenerative . The institution's unique strength lies in integrating large-scale genomic data with clinical research to identify novel therapeutic targets.
The institution hosts 3 researchers tracked in the NeuroWiki database and maintains 2 departments dedicated to neuroscience research^2]. The research programs span Alzheimer's Disease, Genomics, and Systems Biology, contributing to both basic science understanding and translational approaches for neurodegenerative conditions.
History and Milestones
Mount Sinai's journey in neuroscience has been marked by innovation in genomics and translational research.
Key Historical Milestones:
- 1963: Mount Sinai School of Medicine established
- 1990s: Pioneering work in brain banking and neuropathology
- 2000s: Leadership in genome-wide association studies (GWAS)
- 2012: Department of Neuroscience established
- 2015: NIH-funded Alzheimer's Disease Research Center
- 2020: Single-cell genomics in neurodegeneration
Research Programs
Focus Areas
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- Genomics and Genetics
- Systems Biology
- Multi-Omics Approaches
Departments and Centers
- Department of Neuroscience: Comprehensive neuroscience research
- Alzheimer's Disease Research Center: NIH-funded clinical research
- Center for Alzheimer's Disease Research: Translation-focused program
Research Themes
Genomics
- GWAS: Large-scale genetic studies in AD and PD
- Whole Exome/Genome Sequencing: Rare variant discovery
- Epigenomics: [DNA methylation](/entities/dna-methylation) and chromatin states
Systems Biology
- Multi-Omics Integration: Combining genomics, transcriptomics, proteomics
- Network Analysis: Protein-protein interaction networks
- Systems Pharmacology: Computational drug discovery
Biomarkers
- Genetic risk scores
- Blood-based
- Multi-modal
Notable Discoveries and Contributions
Genetics
- AD GWAS: Identification of novel risk genes (CLU, PICALM, CR1)
- [TREM2](/genes/trem2): Validation of TREM2 variants in AD risk
- [APOE](/genes/apoe): Fine-mapping of APOE region
Multi-Omics
- Mount Sinai Brain Bank: Comprehensive molecular profiling
- Accelerating Medicines Partnership: AD biomarker discovery
- Single-Cell Atlas: Cell-type specific changes in AD
Therapeutics
- Novel target identification through genomics
- Systems pharmacology approaches
- Repositioning of existing drugs
Key Researchers
| Researcher | Focus Areas |
|------------|-------------|
| Alison Goate | Genetics, AD |
| Bin Zhang | Systems Biology, Multi-omics |
| Vahram Haroutunian | Neuropathology, Genomics |
Funding and Resources
Major Grants
- NIH ADRC (P50)
- R01 grants in genomics and systems biology
- Foundation grants (Alzheimer's Association, Michael J. Fox)
Research Facilities
- Genomics Core: Next-generation sequencing
- Bioinformatics Core: Computational resources
- Human Brain Bank: Extensive tissue collection
- Clinical Research Unit: Patient recruitment
Clinical Care
Mount Sinai provides comprehensive clinical care through:
- Memory disorders clinic
- Movement disorders program
- Clinical trials unit
- Caregiver support services
Cross-Links to Related Pages
Diseases
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
Genes
- [APOE](/genes/apoe)
- [CLU](/genes/clu)
- [TREM2](/proteins/trem2-protein)
- [PICALM](/genes/picalm)
Mechanisms
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Protein Aggregation](/mechanisms/protein-aggregation)
- Genetics of AD
Key Publications
See Also
- [//overview|Cell Types Overview](/content/cell-types)
- [Gene Overview](/genes)
- [//overview|Disease Overview](/diseases/neurodegeneration)
External Links
- Official Website: https://icahn.mssm.edu/
- Neuroscience Department: https://icahn.mssm.edu/neuroscience
International Collaborations
Mount Sinai leads international genomics efforts:
Major Partnerships
- AMP-AD: Accelerating Medicines Partnership
- International Genomics Consortium
- Global Alliance for Genomics and Health
Future Directions
Emerging Research Areas
- Single-cell analysis: Cell-type resolution
- Systems pharmacology: Computational drug discovery
- Immunotherapy: Novel antibody approaches
Strategic Priorities
Impact and Recognition
Impact
- Major genetic discoveries in AD
- Novel therapeutic targets
- Training future leaders
Research Infrastructure
Core Facilities
Genomics
- Sequencing Core: Whole genome/exome
- Genotyping: GWAS support
- Single-Cell: Cell atlas generation
Bioinformatics
- Computational Cluster: Analysis
- Data Science Team: Support
- Machine Learning: AI/ML
Imaging
- MRI: 3T and 7T scanners
- PET: Molecular imaging
- Microscopy: Advanced imaging
Training Programs
Educational Opportunities
Graduate
- PhD in Biomedical Sciences: Doctoral
- Master's Programs: Research and clinical
Clinical
- Neurology Residency: Training
- Fellowships: Sub-specialty
- Research Training: K12 programs
Distinguished Research Programs
Genomics and Genetics
Alzheimer's Disease Genetics
Mount Sinai is a leader in AD genetics:
- GWAS: Large-scale genetic association studies
- Whole Exome Sequencing: Rare variant discovery
- Functional Genomics: Understanding variant effects
- Genetic Risk Scores: Polygenic risk prediction
Parkinson's Disease Genetics
Research into genetic contributors to PD:
- LRRK2: Common genetic risk factor
- GBA: Glucocerebrosidase gene associations
- SNCA: Alpha-synuclein genetics
- Novel Genes: New genetic discoveries
Research Methodology
Multi-Omics
Genomics
- Whole Genome Sequencing: Comprehensive variant detection
- RNA Sequencing: Gene expression analysis
- Epigenomics: DNA methylation and chromatin states
Proteomics
- Mass Spectrometry: Protein quantification
- Phosphoproteomics: Signaling pathways
- Proteomics Atlas: Protein expression across brain regions
Metabolomics
- Metabolite Profiling: Metabolic changes in disease
- Lipidomics: Membrane lipid alterations
- Integration: Multi-omics integration
Clinical Programs
Patient Care
Memory Disorders Center
Comprehensive care:
- Diagnostic Evaluation: Thorough assessment
- Treatment Options: Current therapies
- Clinical Trials: Access to new treatments
- Caregiver Support: Education and resources
Movement Disorders
Expert Parkinson's care:
- Medication Management: Optimizing treatment
- Surgical Options: DBS evaluation
- Rehabilitation: Comprehensive therapy
- Research: Clinical trials
Training Programs
Educational Excellence
Graduate Training
- PhD in Biomedical Sciences: Doctoral training
- MD/PhD Program: Combined degrees
- Master's Programs: Specialized training
Clinical Training
- Neurology Residency: ACGME program
- Memory Disorders Fellowship: Sub-specialty
- Movement Disorders Fellowship: Advanced training
Future Directions
Emerging Areas
Precision Medicine
- Genetic Stratification: Based on genotype
- Biomarker-Guided: Personalized treatment
- Targeted Therapies: Disease-specific approaches
Computational Biology
- AI Drug Discovery: Machine learning approaches
- Network Analysis: Systems biology
- Predictive Models: Disease progression
Cross-Links to Related Pages
Related Diseases
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Frontotemporal Dementia](/diseases/frontotemporal-dementia)
- [Lewy Body Dementia](/diseases/lewy-body-dementia)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
Related Genes
- [APOE - Major genetic risk factor for AD](/genes/apoe)
- [TREM2 - Dementia risk gene](/proteins/trem2-protein)
- [CLU - Clusterin associated with AD](/genes/clu)
- [PICALM - AD susceptibility gene](/genes/picalm)
- [SNCA - Alpha-synuclein in PD](/genes/snca)
Related Mechanisms
- [Neuroinflammation](/mechanisms/neuroinflammation)
- [Protein Aggregation](/mechanisms/protein-aggregation)
- [Amyloid Cascade Hypothesis](/mechanisms/amyloid-cascade-hypothesis)
- [Tau Pathology](/mechanisms/tau-pathology)
- [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
Related Proteins
- [GSK-3β - Kinase in tau phosphorylation](/companies/gsk)
- [APP - Amyloid precursor protein](/genes/app)
- [Ubiquitin - Protein degradation](/proteins/ubiquitin)
- TDP-43 - ALS protein pathology
Related Cell Types
- [Neurons](/cell-types/neurons)
- [Microglia](/cell-types/microglia)
- [Astrocytes](/cell-types/astrocytes)
- [Oligodendrocytes](/cell-types/oligodendrocytes)
Related Brain Regions
- [Hippocampus](/brain-regions/hippocampus)
- [Substantia Nigra](/brain-regions/substantia-nigra)
- [Cerebral Cortex](/cerebral-cortex)
- [Nucleus Basalis of Meynert](/brain-regions/nucleus-basalis-meynert)
Related Research
- Accelerating Medicines Partnership
- [UK Biobank](/datasets/uk-biobank)
- Human Cell Atlas
Related Therapeutics
- Anti-Amyloid Therapies
- [Tau-Targeting Therapies](/proteins/tau)
- Neuroprotective Strategies
Related Diagnostics
- MRI Neuroimaging
- [PET Imaging](/diagnostics/pet-imaging)
- [CSF Biomarkers](/diagnostics/csf-biomarkers)
- Blood-Based Biomarkers
Related Technologies
- Whole Genome Sequencing
- Single-Cell RNA Sequencing
- Bioinformatics Analysis
Related Institutions
- [NIH](/institutions/nih)
- Alzheimer's Association
- Michael J. Fox Foundation
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | institutions-icahn-sinai |
| kg_node_id | None |
| entity_type | institution |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-5f672f8c052d |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-icahn-sinai'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-institutions-icahn-sinai?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Icahn School of Medicine at Mount Sinai](http://scidex.ai/artifact/wiki-institutions-icahn-sinai)
http://scidex.ai/artifact/wiki-institutions-icahn-sinai